β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer

Theranostics - Tập 9 Số 2 - Trang 324-336 - 2019
Tzu-Lei Kuo1, Kuang‐Hung Cheng2, Yan‐Shen Shan3,4, Li‐Tzong Chen5,6,1, Wen-Chun Hung6,1
1National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan
2Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
3Department of Surgery, National Cheng Kung University Hospital, Tainan, 704, Taiwan
4Institute of Clinical Medicine, National Cheng Kung University, Tainan, 704, Taiwan
5Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan 704, Taiwan.
6Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 804, Taiwan.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Theranostics

Tập 9 Số 2

324-336

Thông tin tác giả